Smarter prescription of azithromycin using machine learning, with Prof. Wim Janssens
Prophylactic use of azithromycin is common in the management of COPD patients with frequent acute exacerbations. But its application is conservative due to concerns around adverse events, interactions with other drugs, and bacterial resistance. Given these concerns, it is important to identify patients who are likely to be responders or non-responders.
According to the NICE guidance in the UK, you should consider azithromycin if the patient:
Doesn't smoke.
Has already accounted for non-drug treatments, inhaled therapies and vaccines.
And has one or more of the following kinds of…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.